Starting from September 1, pharmacy employees may face large fines if they fail to inform customers about the availability of cheaper drug alternatives. This was reported by Associate Professor of the Moscow State Law University named after O.E. Kutafin, Aleksey Kubishkin, writes Pravilamag.
According to him, the new regulation is related to amendments to the “Rules of Good Pharmacy Practice in Medicine,” approved by the Russian Ministry of Health and coming into force on September 1.
The current legislation had already obliged pharmacists and pharmacy managers not to conceal information about the availability of more affordable medicines. However, since the requirements were not clearly defined, now sanctions will be applied in case of such violations.
Employees who do not comply with the rule may be fined from 100,000 to 200,000 rubles. This will be considered a gross violation of licensing conditions, added Kubishkin.
Earlier, it was proposed to introduce liability for pharmacists for the wrong approach in selecting medicines. Research has shown that in 60 percent of cases, pharmacy employees recommend to customers exactly those drugs for which a marketing agreement exists.
Read 'Zamin' on Telegram!
